Notably, chimeric MV H-DARPins targeting HER2/neu—a receptor highly overexpressed in many cancers, such as breast and ovarian—redirected membrane fusion of pseudotyped LVs in xenograft mouse models, demonstrating their in vivo potential [87]. This evidence concerns the gene ERBB2 and cancer.